An Open Label Phase 1 Trial of Losartan for Worsening Respiratory Illness in COVID-19
Latest Information Update: 06 Aug 2024
At a glance
- Drugs Losartan (Primary)
- Indications COVID-19 respiratory infection; Respiratory insufficiency
- Focus Adverse reactions
Most Recent Events
- 02 Nov 2020 Status changed from recruiting to completed.
- 08 Apr 2020 New trial record